Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
In The Search For A COVID Cure, Biopharma ETFs May Keep Your Portfolio Healthy
12:00am, Friday, 17'th Jul 2020
Stocks Analysis by Investing.com (Tezcan Gecgil/Investing.com) covering: Vertex Pharmaceuticals Inc, Gilead Sciences Inc, iShares Nasdaq Biotechnology ETF, Amgen Inc. Read Investing.com (Tezcan Gecgil
Editas Medicine Inc (NASDAQ:EDIT) Shares Bought by Wells Fargo & Company MN
08:26pm, Thursday, 16'th Jul 2020
Wells Fargo & Company MN boosted its stake in shares of Editas Medicine Inc (NASDAQ:EDIT) by 2.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 57
Advisor Group Holdings Inc. Makes New $418,000 Investment in Editas Medicine Inc (NASDAQ:EDIT)
04:52pm, Thursday, 16'th Jul 2020
Advisor Group Holdings Inc. bought a new position in shares of Editas Medicine Inc (NASDAQ:EDIT) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Ex
Brokerages Expect Editas Medicine Inc (NASDAQ:EDIT) Will Post Quarterly Sales of $6.14 Million
07:52pm, Wednesday, 15'th Jul 2020
Brokerages forecast that Editas Medicine Inc (NASDAQ:EDIT) will announce $6.14 million in sales for the current quarter, according to Zacks. Four analysts have issued estimates for Editas Medicine’s
Ocular Therapeutix Announces Its First Published Physician Fee Schedule for Administration of Intracanalicular Inserts
12:00am, Wednesday, 15'th Jul 2020
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative thera
MERIAN GLOBAL INVESTORS UK Ltd Buys Shares of 28,368 Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
07:08am, Tuesday, 14'th Jul 2020
MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) during the second quarter, according to its most recent 13F filing with the SEC. The institut
\-- INFINITY trial is currently enrolling patients with DME, the most common cause of vision loss in people with diabetic retinopathy -- REDWOOD CITY, Calif., July 13, 2020 --.
Gout Therapeutics - Global Market Insights and Forecast 2020-2025 - ResearchAndMarkets.com
12:00am, Monday, 13'th Jul 2020
The
The U.S. Is Bailing Out Companies. Regeneron Doesn’t Need the Help.
04:15pm, Friday, 10'th Jul 2020
The government is deciding who the winners among individual companies are and giving losers another chance. It feels strange and new, even if what it’s spending is peanuts compared with the dollars
APG Asset Management N.V. Purchases 21,377 Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
06:58am, Wednesday, 08'th Jul 2020
APG Asset Management N.V. increased its position in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 70.3% during the 1st quarter, according to its most recent filing with the Securities and E
Governo USA investe in Novavax e Regeneron Pharmaceuticals per l'operazione "Warp Speed" | Invezz
08:01pm, Tuesday, 07'th Jul 2020
Novavax Inc. (NASDAQ: NVAX) ha detto martedì che ha siglato un accordo con il governo degli Stati Uniti che la rende responsabile di consegnare 100 milioni di dosi del suo potenziale vaccino contro i
El gobierno de EE.UU. invierte en Novavax y Regeneron Pharmaceuticals dentro del programa "Operation Warp Speed" | Invezz
05:05pm, Tuesday, 07'th Jul 2020
Novavax Inc. (NASDAQ: NVAX) dijo el martes que firmó un acuerdo con el gobierno de EE.UU. que le obliga a entregar 100 millones de dosis de su vacuna candidata para COVID-19 en los EE.UU. para enero
Virus Worries Weigh on Markets — but Tech Stocks Are Still Rising
04:51pm, Tuesday, 07'th Jul 2020
The Dow Jones Industrial Average is 0.9% lower in recent trading, while the S&P 500 is off 0.3%. The Nasdaq Composite is up 0.1%.
COVID-19 vaccine candidates secure funds; Lysol gets EPA nod
04:11pm, Tuesday, 07'th Jul 2020
Novavax has received $1.6 billion from the federal government to complete late-stage clinical development; establish large-scale manufacturing; and deliver 100 million doses of NVX‑CoV2373, its COVI
